Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-08

FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Zhejiang Yongtai Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for Rosuvastatin Calcium from Zhejiang Yongtai Pharmaceutical Co., Ltd., resulting in an approved supplement to the ANDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

SUPPL AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)